Products
Online Inquiry

Please note that we are not a pharmacy or clinic, so we are unable to see patients and do not offer diagnostic and treatment services for individuals.

Vitamin B12 test kit

Apremilast (CC-10004)

Cat. No.: OB0225WX-2724
Appearance: Solid
Purity: ≥99%
Identity: Confirmed by NMR, and HPLC.
Size:
Apremilast (CC-10004)
Add to basket

Product Overview

Description: Apremilast is an orally active dual inhibitor targeting PDE4 and TNF-alpha, with measured IC50 values of 74 nM and 77 nM, respectively.
Synonym: CC-10004; 608141-41-9; Apremilast; CC 10004; Apremilast (CC-10004); CC10004; Apremilastum; (S)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione; (S)-N-(2-(1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl)-1,3-dioxoisoindolin-4-yl)acetamide; N-{2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl}acetamide; N-{2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-methanesulfonylethyl]-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl}acetamide; (+)-N-(2-((1S)-1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl)-1,3-dioxo- 2,3-dihydro-1H-isoindol-4-yl)acetamide; N-[2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-1,3-dioxoisoindol-4-yl]acetamide; MFCD18782607; (S)-N-{2-[1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl}-acetamide; 4-[[5 pound not7-dihydroxy-2 pound not2-dimethyl-8-(2-methylpropanoyl)chromen-6-yl]methy l]-3 pound not5-dihydroxy-6 pound not6-dimethyl-2-(2-methylpropanoyl)cyclohexa-2 pound not4-dien- 1-one; A9L; Acetamide, N-(2-((1S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl)- 2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl)-
CAS No.: 608141-41-9
Compound CID: 11561674
Formula: C22H24N2O7S
Formula Weight: 460.5

Specification

Stability: 3 years in powder form.
Storage: Storage at -20°C.
Applications: Apremilast is applied in inflammatory research as a potent and selective PDE4 inhibitor to investigate the modulation of intracellular cAMP levels and the subsequent reduction of pro-inflammatory mediator production.

Library Information

Target: PDE; TNF-alpha
Receptor: PDE4; TNF-alpha
Pathways: Metabolism
Plate Number: L6700-09
Empty Location: a1-h1; a12-h12
Container: 96-well plate
Formulation: 10mM DMSO
DMSO Max Solubility: 92 mg/mL; 199.78 mM
ALogP: 1.509
HBA_Count: 7
HBD_Count: 1
Rotatable Bond: 8
Inquiry
0
Inquiry Basket
Check Out

Copyright © Protheragen. All rights reserved.